The Food and Drug Administration on Thursday classified the voluntary recall of certain respiratory masks made by ResMed as “most serious” as their incorrect use could cause major injuries or death.
The last 12 months have been nothing short of a whirlwind for ResMed. After finding itself scrambling to pick up the slack left in the wake of Philips’ massive respiratory device recall last June, it ...
GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds. ResMed (NYSE: RMD) finds itself in an investment limbo ...
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...